Compounds > farnesol

farnesol and Allergic Encephalomyelitis

farnesol has been researched along with Allergic Encephalomyelitis in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	2 (50.00)	2.80

Authors

Authors	Studies
Doyle, WJ; Hoffman, K; Magori, K; Ochoa-Repáraz, J; Roullet, JB; Shi, X; Walters, D	1
Bains, JK; Doyle, WJ; Gibson, KM; Hevrin, T; Hoffman, K; Kirby, TO; Kohl, HM; Ochoa-Repáraz, J; Ramelow, CC; Roullet, JB; Sell, LB; Strawn, KD	1
Aizman, E; Assaf, Y; Chapman, J; Kloog, Y; Mor, A	1
Abramsky, O; Chapman, J; Grigoriadis, N; Karussis, D; Kloog, Y; Mizrachi-Koll, R; Niv, H	1

Reviews

1 review(s) available for farnesol and Allergic Encephalomyelitis

Article	Year
Farnesol induces protection against murine CNS inflammatory demyelination and modifies gut microbiome. Clinical immunology (Orlando, Fla.), 2022, Volume: 235 Topics: Administration, Oral; Animals; Encephalomyelitis, Autoimmune, Experimental; Farnesol; Female; Gastrointestinal Microbiome; Mice	2022

Other Studies

3 other study(ies) available for farnesol and Allergic Encephalomyelitis

Article	Year
Farnesol brain transcriptomics in CNS inflammatory demyelination. Clinical immunology (Orlando, Fla.), 2023, Volume: 255 Topics: Animals; Brain; Encephalomyelitis, Autoimmune, Experimental; Farnesol; Humans; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Transcriptome	2023
The combined treatment of Copaxone and Salirasib attenuates experimental autoimmune encephalomyelitis (EAE) in mice. Journal of neuroimmunology, 2010, Dec-15, Volume: 229, Issue:1-2 Topics: Animals; Carrier Proteins; CD3 Complex; Cell Proliferation; Cytokines; Demyelinating Diseases; Disease Models, Animal; DNA Helicases; Drug Synergism; Drug Therapy, Combination; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Extracellular Signal-Regulated MAP Kinases; Farnesol; Female; Forkhead Transcription Factors; Glatiramer Acetate; Immunosuppressive Agents; Leukemic Infiltration; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Peptides; Poly-ADP-Ribose Binding Proteins; RNA Helicases; RNA Recognition Motif Proteins; Salicylates; Spinal Cord; Spleen; Statistics, Nonparametric; Time Factors	2010
The Ras-pathway inhibitor, S-trans-trans-farnesylthiosalicylic acid, suppresses experimental allergic encephalomyelitis. Journal of neuroimmunology, 2001, Nov-01, Volume: 120, Issue:1-2 Topics: Animals; Antigens, Surface; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; Down-Regulation; Drug Administration Schedule; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Farnesol; Female; Lymphocyte Activation; Lymphocytes; Mice; Myelin Proteins; Myelin Sheath; Paralysis; ras Proteins; Salicylates; Survival Rate; Treatment Outcome	2001